Gainers
- Zosano Pharma Corp (NASDAQ:ZSAN) shares are up 13 percent. Earlier in the day, the company issued a mid-day press release highlighting added analysis from ZOTRIP study will be present at AHS meeting.
- Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) shares are up 9 percent. On Tuesday, the company said it won’t provide ALS Stem CEll treatment under ‘Right to Try’ Act due to failure to find a way for all patients to afford treatment.
- Mongodb Inc (NASDAQ:MDB) shares are up 8 percent. The MongoDB World 2018 event concluded on Wednesday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Losers
- Pier 1 Imports Inc (NYSE:PIR) shares are down 15 percent after reporting a first-quarter earnings miss. Earnings came in at $(0.36), missing estimates by 3 cents. Sales came in at $372 million, missing estimates by $4 million. Comps were down 8.2 percent in the quarter. The company sees comps down 6-7 percent in the second quarter.
- Bed Bath & Beyond Inc. (NASDAQ:BBBY) shares are down 5 percent after earnings fell in-line with analyst estimates in the first quarter at 32 cents per share. Sales came in slightly ahead of estimates at $2.754 billion, beating estimates by $4 million. Comps were down 0.6 percent in the quarter.